BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23318282)

  • 1. Discrimination of prohibited oral use from authorized inhaled treatment of budesonide in sports.
    Matabosch X; Pozo OJ; Pérez-Mañá C; Farré M; Marcos J; Segura J; Ventura R
    Ther Drug Monit; 2013 Feb; 35(1):118-28. PubMed ID: 23318282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budesonide use and misuse in sports: Elimination profiles of budesonide and metabolites after intranasal, high-dose inhaled and oral administrations.
    Coll S; Monfort N; Matabosch X; Papakonstantinou K; Pérez-Mañá C; Mateus JA; Ventura R
    Drug Test Anal; 2020 May; 12(5):629-636. PubMed ID: 31306564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of budesonide metabolites in human urine after oral administration.
    Matabosch X; Pozo OJ; Pérez-Mañá C; Farré M; Marcos J; Segura J; Ventura R
    Anal Bioanal Chem; 2012 Aug; 404(2):325-40. PubMed ID: 22573060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children.
    Agertoft L; Pedersen S
    Am J Respir Crit Care Med; 2003 Oct; 168(7):779-82. PubMed ID: 12893646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the reporting level to detect triamcinolone acetonide misuse in sports.
    Matabosch X; Pozo OJ; Pérez-Mañá C; Papaseit E; Marcos J; Segura J; Ventura R
    J Steroid Biochem Mol Biol; 2015 Jan; 145():94-102. PubMed ID: 25260353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of budesonide in human urine after inhalation by liquid chromatography-mass spectrometry.
    Deventer K; Mikulcíková P; Van Hoecke H; Van Eenoo P; Delbeke FT
    J Pharm Biomed Anal; 2006 Oct; 42(4):474-9. PubMed ID: 16842962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using complementary mass spectrometric approaches for the determination of methylprednisolone metabolites in human urine.
    Pozo OJ; Marcos J; Matabosch X; Ventura R; Segura J
    Rapid Commun Mass Spectrom; 2012 Mar; 26(5):541-53. PubMed ID: 22302494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
    Ohbayashi H; Yamase H
    Arerugi; 2003 Jan; 52(1):31-8. PubMed ID: 12598720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
    Zangrilli J; Mansfield LE; Uryniak T; O'Brien CD
    Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and characterization of prednisolone metabolites in human urine by LC-MS/MS.
    Matabosch X; Pozo OJ; Pérez-Mañá C; Papaseit E; Segura J; Ventura R
    J Mass Spectrom; 2015 Mar; 50(3):633-42. PubMed ID: 25800201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BUDESONIDE TREATMENT OF PROFESSIONAL ATHLETES AND ANTI-DOPING TESTING--CASE STUDIES.
    Kaliszewski P; Kończak D; Chołbiński P; Wicka M; Michalak D; Kwiatkowska D; Lewandowska-Pachecka S; Namieśnik J; Pokrywka A
    Acta Pol Pharm; 2016; 73(1):229-37. PubMed ID: 27008817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary profile of methylprednisolone and its metabolites after oral and topical administrations.
    Matabosch X; Pozo OJ; Monfort N; Pérez-Mañá C; Farré M; Marcos J; Segura J; Ventura R
    J Steroid Biochem Mol Biol; 2013 Nov; 138():214-21. PubMed ID: 23792784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological and clinical profile of Budesonide inhalation suspension (Pulmicort inhalation liquid), an inhaled steroid drug for asthma].
    Watanabe H; Yano S; Kageyama A
    Nihon Yakurigaku Zasshi; 2007 Mar; 129(3):197-207. PubMed ID: 17379972
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
    Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
    N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma.
    Evans DJ; Taylor DA; Zetterstrom O; Chung KF; O'Connor BJ; Barnes PJ
    N Engl J Med; 1997 Nov; 337(20):1412-8. PubMed ID: 9358138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Metabolic Profile of Inhaled Budesonide and Salbutamol in Asthmatic Children during Acute Exacerbation.
    Quan-Jun Y; Jian-Ping Z; Jian-Hua Z; Yong-Long H; Bo X; Jing-Xian Z; Bona D; Yuan Z; Cheng G
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):303-311. PubMed ID: 27730746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment.
    Bergés R; Segura J; Ventura R; Fitch KD; Morton AR; Farré M; Mas M; de La Torre X
    Clin Chem; 2000 Sep; 46(9):1365-75. PubMed ID: 10973867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide quantification by HPLC coupled to atmospheric pressure photoionization (APPI) tandem mass spectrometry. Application to a comparative systemic bioavailability of two budesonide formulations in healthy volunteers.
    Borges NC; Astigarraga RB; Sverdloff CE; Borges BC; Paiva TR; Galvinas PR; Moreno RA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(3-4):236-42. PubMed ID: 21233029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination profiles of betamethasone after different administration routes: Evaluation of the reporting level and washout periods to ensure safe therapeutic administrations.
    Coll S; Monfort N; Alechaga É; Matabosch X; Pérez-Mañá C; Ventura R
    Drug Test Anal; 2021 Feb; 13(2):348-359. PubMed ID: 32949107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.